MOUNTAIN VIEW, Calif., Aug. 2, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Beaumont Health, the largest health system in Michigan, has selected the company's medication management platform to support eight hospitals across the system. New automation on hospital floors, as well as in anesthesia procedural areas and the central pharmacy, will help improve medication security and safety. Additionally, Performance Center™, which combines a cloud-based predictive intelligence platform with ongoing optimization services, will empower the health system to leverage medication usage data to help improve patient outcomes.
According to the Healthcare Financial Management Association, a health system's current business technology typically includes numerous proprietary databases for specific financial and clinical functions.i In an effort to consolidate these various data sources across the health system, leaders at Beaumont Health sought a solution that would offer a single, enterprise-wide IT infrastructure, making it easier to track medication and monitor usage across various facilities and make more strategic medication management decisions.
Further, the addition of Omnicell® Analytics along with the XT Series Automated Dispensing Cabinets helps enhance safety and security of all classes of medications. The new cabinets also provide increased storage capacity, giving nurses improved access to medications while minimizing restocks from central pharmacy. Interoperability with the health system's electronic health record enables remote medication queuing that allows nurses to spend more time at the patient bedside.
"We're always looking for ways to streamline our processes, enhance visibility and improve operations across our health system," said Kathleen Pawlicki, BS, MS, FASHP, vice president, chief pharmacist at Beaumont Health. "Beyond helping to improve medication security at the point of care, working with Omnicell will help us make smarter business decisions in our pharmacy and across our hospitals, which will allow our clinicians to provide better care to our patients."
"The number of patients and staff included under the umbrella of Beaumont Health is astounding, yet the health system continues to deliver the highest quality of care to each patient," said Nhat Ngo, executive vice president, Marketing, Strategy & Business Development at Omnicell. "Beaumont recognizes the importance of scalable, enterprise-wide solutions to support continued growth. We will offer new efficiencies and cost savings to enhance Beaumont's clinical offerings as the system transforms its medication management strategy from facility-based to enterprise-wide."
About Beaumont Health
Beaumont Health is Michigan's largest health care system for inpatient admissions and net patient revenue and is most preferred for health care in the tri-county area, according to National Research Corp. survey data. A not-for-profit organization, it was formed in 2014 by Beaumont Health System, Botsford Hospital and Oakwood Healthcare to provide patients with the benefit of greater access to extraordinary, compassionate care, no matter where they live in Southeast Michigan. Beaumont Health has total net revenue of $4.4 billion and consists of eight hospitals with 3,429 beds, 187 outpatient sites, nearly 5,000 physicians, 38,000 employees and 3,500 volunteers. In 2017, Beaumont Health had 175,688 inpatient discharges, 17,789 births and 574,591 emergency visits. For more information, visit beaumont.org.
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.
Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,500 facilities worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.
Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.
For more information about Omnicell, Inc. please visit www.omnicell.com.
- All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.
i HFMA, "From Disparate Data to Informed Strategies: Using Technology to Transform Quality, Costs, and the Patient Experience." (February 2018) https://www.hfma.org/Content.aspx?id=59345
View original content with multimedia:http://www.prnewswire.com/news-releases/beaumont-health-selects-omnicells-medication-management-platform-and-services-to-support-improved-financial-and-clinical-performance-300691003.html
SOURCE Omnicell, Inc.
Betsy Martinelli, Omnicell, Inc., (724) 741-8341, email@example.com; or Jessika Parry, Next Step Communications, (781) 326-1741, firstname.lastname@example.org